The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Is Shared Decision Making Possible in Rheumatology?

Is Shared Decision Making Possible in Rheumatology?

August 1, 2014 • By James T. Rosenbaum, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Shared decision making is an admirable ideal.

You Might Also Like
  • Engage Patients as Partners in Shared Decision-making
  • Why & How Doctors Should Foster Shared Decision Making with Patients
  • Why & How to Pursue Shared Decision Making with Your Patients
Explore This Issue
August 2014
Also By This Author
  • Fatal Choices: Mixing Risk with Medicine

Medicine has entered the era of shared decision making. I embrace this movement, and my bias is that rheumatologists as a group are uniquely suited to implement shared decision making successfully. But I am skeptical that true shared decision making is an achievable goal.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Shared decision making requires explaining options without bias. But each of us is a product of our environment, with inescapable preconceptions. Even if our intention is to provide nonjudgmental advice, we deceive ourselves if we believe that this is possible.

Patient Example 1

At age 40, Elaine had already endured a lifetime of disease. She had successfully overcome substance abuse, but she had not escaped the ravages of sarcoidosis that affected her lungs, liver, skin and eyes. The prednisone needed to treat the sarcoidosis had resulted in poorly controlled diabetes.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Despite the therapy, her impaired pulmonary function left her oxygen dependent, and her serum alkaline phosphatase was 10 times higher than normal due to her liver involvement. She was fortunate that her disease responded to costly therapy with a monoclonal antibody to tumor necrosis factor alpha (TNFα) such that both her lungs and liver markedly improved.

When Elaine became pregnant, all of her treating physicians gave her the same advice: Pregnancy was too great a risk to her and to the fetus. The pregnancy was terminated. A year later, Elaine became pregnant again, and again she was advised to terminate the pregnancy. She elected to ignore this advice.

I cared for Elaine as her physician before she became pregnant. I recommended the antibody therapy, which does not have an FDA-approved indication for use in sarcoidosis. I argued with her insurer to cover the cost of this therapy, which both Elaine and I believe saved her life. And I disagreed with Elaine when, despite concerns about her own health, she refused to terminate her second pregnancy. She is now the mother of an energetic 6-year-old boy, whom she aptly calls her miracle baby.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

And I am still her doctor.

Where Values Intersect

Providing care for a patient results in the meeting of two value systems: the physician’s and the patient’s.

Some might argue that in a perfect world, the physician is an advisor, and the values of the patient should ultimately prevail. This is the essence of patient-centered care. But let’s assume the patient wants to take a naturopathic remedy the physician considers harmful. Is the physician obligated to object? Although the physician perceives their advice to be well reasoned, the patient most likely perceives the same advice as judgmental. Some patients with back pain may request magnetic resonance imaging and others might demand antibiotic therapy to treat their respiratory congestion. Is it good judgment to say no to these requests?

Pages: 1 2 3 | Single Page

Filed Under: Biologics & Biosimilars, Conditions, DMARDs & Immunosuppressives, Drug Updates, Practice Management, Quality Assurance/Improvement, Rheumatoid Arthritis, Systemic Inflammatory Syndromes, Workforce Tagged With: Biologics, drug, Medicare, metho­trexate, patient care, physician, Practice Management, prednisone, Rheumatoid arthritis, rheumatologist, Sarcoidosis, SteroidsIssue: August 2014

You Might Also Like:
  • Engage Patients as Partners in Shared Decision-making
  • Why & How Doctors Should Foster Shared Decision Making with Patients
  • Why & How to Pursue Shared Decision Making with Your Patients
  • Shared Decision Making, Good Disease Control Are Key Components of JIA Management

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)